ClinicalTrials.Veeva

Menu

Bone Marrow Aspirate Concentrate in Treating Mandibular Cystic Defects

H

Hams Hamed Abdelrahman

Status

Completed

Conditions

Mandible Cyst

Treatments

Other: Conventional enucleation only
Other: Enucleation and filling by Bone marrow aspirate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Mandibular cystic defect healing is a complex process. Various methods have been developed to shorten the bone regeneration time and improve its quality. Autogenous grafting is the gold standard for filling cystic defects due to the osteogenesis property provided by the viable cells but is related to donor site morbidity. Allografts and Xenografts are used for the same purpose. However, the increased cost is their main disadvantage. Bone marrow aspirate concentrate is now used to enhance the healing and regeneration process in many areas of the body with no morbidity and low cost.

Enrollment

16 patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients suffering from mandibular cystic defect.
  • Cystic defect width of 4-8 cm that requires removal under general anesthesia.

Exclusion criteria

  • Medically compromised patients contradicting operation.
  • Previously enucleated lesions.
  • Previous surgery, tumor, infection to the pelvis affecting the anterior iliac crest.
  • Infected Cysts

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

16 participants in 2 patient groups

Test group
Experimental group
Treatment:
Other: Enucleation and filling by Bone marrow aspirate
Control group
Active Comparator group
Treatment:
Other: Conventional enucleation only

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems